Imax stock hits 52-week high at 29.66 USD

Published 05/09/2025, 17:34
Imax stock hits 52-week high at 29.66 USD

Imax Corporation’s stock reached a new 52-week high, hitting $29.66, marking a significant milestone for the $1.59 billion market cap company. InvestingPro analysis shows the stock is trading at a P/E ratio of 47.6, with analysts maintaining a strong buy consensus. This achievement reflects a robust performance, with the stock delivering a 14.1% year-to-date return and strong momentum. The company’s stock has been on an upward trajectory, driven by a resurgence in demand for its large-format film experiences and strategic partnerships. According to InvestingPro, which offers comprehensive analysis through its Pro Research Reports covering 1,400+ stocks, IMAX shows promising financial health metrics. This 52-week high is a testament to Imax’s successful navigation of the post-pandemic entertainment landscape, positioning itself as a leader in the industry. With strong liquidity and moderate debt levels, the company appears well-positioned for future growth.

In other recent news, IMAX Corporation has been highlighted by Benchmark, which reiterated its Buy rating, citing a strong third-quarter box office performance. The firm noted that IMAX is on track to exceed third-quarter expectations, with global box office revenues already reaching approximately $240 million. Additionally, IMAX has expanded its credit facility, increasing its borrowing capacity from $300 million to $375 million, with an option to extend it further to $515 million. This expansion was completed with a syndicate of seven lenders, led by Wells Fargo Securities, LLC.

IMAX has also announced a significant agreement with Apple Cinemas to install five IMAX with Laser systems across the United States, including a return to Philadelphia in 2026 at Riverview Plaza. In Australia, IMAX and HOYTS Cinemas have entered into a new agreement to open up to five new theaters, with the first set to launch in Melbourne in 2025. Benchmark has also maintained its Buy rating on IMAX amid potential competition from other theater chains considering a joint premium large format brand. These developments underscore IMAX’s strategic growth initiatives and financial maneuvers.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.